标题
The impact of size on particulate vaccine adjuvants
作者
关键词
-
出版物
Nanomedicine
Volume 9, Issue 17, Pages 2671-2681
出版商
Future Medicine Ltd
发表日期
2014-12-22
DOI
10.2217/nnm.14.193
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
- (2013) M. Villa et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
- (2013) Xinran Li et al. JOURNAL OF CONTROLLED RELEASE
- Biodistribution and Pharmacokinetics of EGFR-Targeted Thiolated Gelatin Nanoparticles Following Systemic Administration in Pancreatic Tumor-Bearing Mice
- (2013) Jing Xu et al. MOLECULAR PHARMACEUTICS
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
- (2013) Samuele Calabro et al. VACCINE
- Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep
- (2013) Anita Gamvrellis et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Vaccine Adjuvants: Mode of Action
- (2013) Ennio De Gregorio et al. Frontiers in Immunology
- Biodegradable Particles as Vaccine Delivery Systems: Size Matters
- (2012) Vijaya B. Joshi et al. AAPS Journal
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Development of a nanoparticle-based influenza vaccine using the PRINT® technology
- (2012) Ashley L. Galloway et al. Nanomedicine-Nanotechnology Biology and Medicine
- Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
- (2012) Douglas S. Watson et al. VACCINE
- License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems
- (2011) Camilla Foged et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant
- (2011) Siddhartha Jain et al. Expert Review of Vaccines
- A comparison of anionic nanoparticles and microparticles as vaccine delivery systems
- (2011) Janet Wendorf et al. Human vaccines & immunotherapeutics
- The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production
- (2011) Malou Henriksen-Lacey et al. JOURNAL OF CONTROLLED RELEASE
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
- (2011) Sandra Morel et al. VACCINE
- Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design
- (2010) Xinran Li et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
- (2010) Moses O Oyewumi et al. Expert Review of Vaccines
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
- (2010) T. Vesikari et al. PEDIATRICS
- Measurement of nanoparticles by light-scattering techniques
- (2010) Satinder K. Brar et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Immunology of TLR-independent vaccine adjuvants
- (2009) Ennio De Gregorio et al. CURRENT OPINION IN IMMUNOLOGY
- Mechanism of action of clinically approved adjuvants
- (2009) Bart N Lambrecht et al. CURRENT OPINION IN IMMUNOLOGY
- Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy
- (2009) Marian E Gindy et al. Expert Opinion on Drug Delivery
- Liposome-based cationic adjuvant formulations (CAF): Past, present, and future
- (2009) Dennis Christensen et al. JOURNAL OF LIPOSOME RESEARCH
- Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection
- (2009) Jamie F.S. Mann et al. VACCINE
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alum adjuvanticity: Unraveling a century old mystery
- (2008) Ennio De Gregorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Epaxal®: a virosomal vaccine to prevent hepatitis A infection
- (2008) Patrick A Bovier Expert Review of Vaccines
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
- (2007) Marie Gaumet et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search